GO:0004536 DNA nuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004536 DNA nuclease activity is a molecular function defined as the catalysis of cleavage of ester linkages within deoxyribonucleic acid.
• DNA nucleases include restriction enzymes, CRISPR-associated effectors such as Cas9 and Cas12a2, Exo1, and short Argonaute proteins that degrade DNA.
• Cas9 can exhibit trans-nuclease activity activated by DNA or RNA target binding, expanding its DNA cleavage repertoire beyond programmed sites.
• Cas12a2 triggers abortive infection by RNA-triggered destruction of dsDNA, and this activity can be harnessed for RNA-triggered cell killing.
• DNA-targeting short Argonautes complex with effector proteins to mediate collateral nuclease activity and bacterial population immunity.
• Nuclease activity can be monitored by X-ray scattering interferometry using gold nanoparticle-conjugated DNA and tuned by DNA-nanoparticle conjugate properties.
Description
DNA nuclease activity (GO:0004536) is a fundamental molecular function that catalyzes the cleavage of ester linkages within deoxyribonucleic acid. This activity is essential for DNA repair, recombination, defense against foreign nucleic acids, and programmed cell death. Researchers study DNA nucleases to understand genome stability, host-pathogen interactions, and to develop tools for gene editing and molecular diagnostics. The importance of DNA nuclease activity extends across all domains of life, from restriction enzymes used in molecular biology to CRISPR-associated nucleases that provide adaptive immunity in bacteria. Recent discoveries have revealed unexpected modes of DNA nuclease activity, such as trans-nuclease activity of Cas9 activated by DNA or RNA target binding, and RNA-triggered destruction of dsDNA by Cas12a2. These findings highlight the diversity and regulatory complexity of DNA nucleases. Understanding the mechanisms, genes, and regulation of DNA nuclease activity is critical for both basic research and therapeutic applications, including the development of CRISPR-based tools and antimicrobial strategies.
DNA nuclease activity At A Glance
| GO ID | GO:0004536 |
|---|---|
| GO term | DNA nuclease activity |
| Ontology | molecular_function |
| Synonym | caspase-activated deoxyribonuclease activity, deoxyribonuclease activity |
| Major function | Catalysis of the cleavage of ester linkages within deoxyribonucleic acid |
| Representative enzymes | Restriction enzymes, Cas9, Cas12a2, Exo1, short Argonautes |
| Biological context | DNA repair, recombination, defense against foreign DNA, programmed cell death |
| Research methods | X-ray scattering interferometry, nanoparticle conjugates, biochemical assays |
What Is GO:0004536?
According to the Gene Ontology, GO:0004536 DNA nuclease activity is defined as the catalysis of the cleavage of ester linkages within deoxyribonucleic acid. This molecular function encompasses enzymes that hydrolyze the phosphodiester bonds of DNA, resulting in the breakage of the DNA backbone. Synonyms include caspase-activated deoxyribonuclease activity and deoxyribonuclease activity. This activity can be executed by a wide range of proteins, including restriction enzymes, exonucleases, endonucleases, and CRISPR-associated nucleases, and it is fundamental to processes such as DNA repair, recombination, and defense against foreign DNA.
Why Is DNA nuclease activity Important in Cell Biology?
DNA nuclease activity is central to genome maintenance and host defense, and its dysregulation is linked to numerous diseases. Understanding this activity is essential for developing gene editing tools, antimicrobials, and cancer therapies. The ability to monitor and modulate DNA nuclease activity enables precise manipulation of genomes and provides insights into fundamental biological processes.
• Enables DNA repair and recombination, maintaining genome stability.
• Provides defense against foreign DNA in bacteria and archaea.
• Underlies CRISPR-Cas adaptive immunity and gene editing technologies.
• Involved in programmed cell death and apoptosis.
• Dysregulation contributes to cancer and neurodegenerative diseases.
• Target for antimicrobial and antiviral therapies.
• Facilitates molecular cloning and DNA manipulation in research.
• Can be monitored using advanced biophysical techniques.
• Engineered nucleases are used for genome editing and diagnostics.
• Understanding collateral nuclease activity informs biosafety and tool design.
What Happens During DNA nuclease activity?
Substrate recognition and binding
In simple terms: The nuclease first finds and attaches to its DNA target.
DNA nucleases recognize specific DNA sequences or structures. For example, restriction enzymes bind to specific recognition sites, while CRISPR-associated nucleases like Cas9 are guided by RNA to complementary DNA sequences. Exo1 requires DNA duplex recognition to activate its nuclease activity. Short Argonautes complex with effector proteins to target DNA.
Catalytic cleavage of phosphodiester bonds
In simple terms: The enzyme cuts the DNA backbone.
Once bound, the nuclease catalyzes the hydrolysis of ester linkages within DNA. Cas9 can exhibit trans-nuclease activity activated by DNA or RNA target binding, leading to cleavage of non-target DNA. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA. This cleavage can be sequence-specific or collateral.
Conformational changes and activation
In simple terms: The enzyme changes shape to become active.
DNA binding induces conformational changes that activate the nuclease. For instance, DNA duplex recognition activates Exo1 nuclease activity. Cas9 activation by target binding triggers trans-nuclease activity. These structural transitions are critical for regulation.
Collateral and trans-nuclease activity
In simple terms: Some nucleases cut DNA indiscriminately after activation.
Cas12a2 and short Argonautes exhibit collateral nuclease activity, degrading non-specific DNA to confer population immunity. Cas9 trans-nuclease activity can be activated by DNA or RNA target binding. This activity can be harnessed for RNA-triggered cell killing.
Key Genes Involved in GO:0004536 DNA nuclease activity
The following genes and proteins are key players in DNA nuclease activity, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cas9 | RNA-guided DNA endonuclease; exhibits trans-nuclease activity | Genome editing, trans-cleavage studies |
| Cas12a2 | RNA-triggered dsDNA destruction | Abortive infection, cell killing |
| Exo1 | Exonuclease activated by DNA duplex recognition | DNA repair, recombination |
| Short Argonaute proteins | Complex with effectors for collateral nuclease activity | Bacterial immunity, population defense |
| Restriction enzymes | Sequence-specific DNA cleavage | Molecular cloning, diagnostics |
| DNase I | Non-specific DNA degradation | Apoptosis, sample preparation |
| Caspase-activated DNase | DNA fragmentation during apoptosis | Cell death research |
| Mre11 | Endonuclease/exonuclease in DNA repair | Genome stability |
| Rad27 | Flap endonuclease | DNA replication and repair |
| FEN1 | Flap endonuclease | Okazaki fragment processing |
| RecBCD | Exonuclease and helicase | Recombination |
| Cas12a | DNase with collateral activity | Diagnostics, editing |
| Argonaute (pAgo) | DNA-guided nuclease | Prokaryotic immunity |
| TREX1 | Exonuclease | Autoimmunity |
| APEX1 | AP endonuclease | Base excision repair |
| XPF-ERCC1 | Structure-specific nuclease | Nucleotide excision repair |
| MUS81 | Structure-specific nuclease | Replication fork repair |
| SLX4 | Scaffold for nucleases | DNA repair |
How Is DNA nuclease activity Regulated?
DNA nuclease activity is tightly regulated at multiple levels. For example, Exo1 nuclease activity is activated by DNA duplex recognition, ensuring it acts only at appropriate DNA structures. Cas9 trans-nuclease activity is triggered by target binding, providing a switch-like control. Cas12a2 is activated by RNA, linking its destructive activity to infection signals. Short Argonautes require complex formation with effector proteins for collateral activity. These regulatory mechanisms prevent unintended DNA damage and are critical for cellular homeostasis.
DNA nuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Exo1 | Cancer, genome instability | Knockout cell lines, xenografts |
| TREX1 | Aicardi-Goutieres syndrome | Knock-in mouse models |
| Cas12a2 | Bacterial infection, abortive infection | Bacterial knockout, phage challenge |
| Short Argonaute | Bacterial immunity | Overexpression in bacteria |
| FEN1 | Cancer, replication stress | Point mutation knock-in |
Cancer and genome instability
Dysregulation of DNA nucleases such as Exo1 and FEN1 can lead to genome instability and cancer. Exo1 is involved in DNA repair and its altered activity is associated with cancer progression. Targeting DNA nuclease activity is a potential therapeutic strategy.
Autoimmune and inflammatory diseases
Mutations in TREX1, a DNA exonuclease, cause autoimmune diseases such as Aicardi-Goutieres syndrome. Defective clearance of DNA triggers innate immune responses.
Bacterial infections and antimicrobial resistance
CRISPR-Cas systems, including Cas12a2 and short Argonautes, provide defense against phages and plasmids. Harnessing these nucleases can lead to novel antimicrobials.
Neurodegeneration
Defects in DNA repair nucleases contribute to neurodegenerative disorders such as amyotrophic lateral sclerosis and Alzheimer's disease. Oxidative DNA damage and impaired repair are implicated.
From DNA nuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Exo1 nuclease activity require DNA duplex recognition? | Point mutation of Exo1 catalytic residues |
| Can Cas9 trans-nuclease activity be activated by RNA? | Knock-in of Cas9 variants, in vitro cleavage assays |
| What is the role of Cas12a2 in abortive infection? | Knockout of Cas12a2 in bacteria, phage infection |
| How do short Argonautes mediate collateral activity? | Overexpression of Argonaute and effector proteins |
| Can DNA nuclease activity be monitored in real time? | Tagged knock-in with fluorescent reporters |
| What is the impact of TREX1 mutations on autoimmunity? | Knock-in mouse models |
How to Study the DNA nuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray scattering interferometry | Nuclease activity in real time | Monitoring DNA cleavage |
| Nanoparticle conjugate assays | Modulation of nuclease activity | Sensor development |
| In vitro cleavage assays | DNA cleavage efficiency | Enzyme characterization |
| CRISPR screens | Genes affecting nuclease activity | Functional genomics |
| Phage infection assays | Abortive infection | Bacterial immunity |
| Fluorescence resonance energy transfer | DNA cleavage kinetics | High-throughput screening |
| Electrophoretic mobility shift assay | DNA binding | Protein-DNA interactions |
X-ray scattering interferometry
This method uses gold nanoparticle-conjugated DNA to monitor nuclease activity in real time, providing structural insights.
Nanoparticle-based assays
Tuning DNA-nanoparticle conjugate properties allows modulation of nuclease activity, enabling sensitive detection.
Biochemical cleavage assays
In vitro assays with purified nucleases and DNA substrates measure cleavage efficiency and specificity.
CRISPR-based screening
Genome-wide knockout or activation screens identify genes regulating DNA nuclease activity and collateral effects.
How CRISPR Can Be Used to Study GO:0004536 DNA nuclease activity
Knockout
CRISPR knockout of DNA nuclease genes such as Exo1 or Cas12a2 can reveal their roles in DNA repair and bacterial immunity. Knockout cell lines are essential for loss-of-function studies.
Point Mutation
Introducing point mutations in catalytic residues of nucleases like Exo1 or Cas9 allows precise dissection of their enzymatic activity and substrate specificity.
Knock-in
Knock-in of tagged or variant nucleases enables real-time monitoring and functional analysis. For example, knock-in of fluorescently tagged Cas9 allows imaging of DNA cleavage.
Overexpression
Overexpression of DNA nucleases such as short Argonautes or Cas12a2 can induce collateral DNA degradation and cell killing, useful for antimicrobial strategies.
How EDITGENE Supports DNA nuclease activity Research
Researchers studying DNA nuclease activity-related genes often need to determine whether a candidate gene is causally involved in DNA cleavage, repair, or immunity. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for DNA nuclease activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DFFB Knockout HEK293 Cell Line | EDJ-KQ1302 | Human | 1677 | Details Get a Quote |
| DNASE1L3 Knockout HEK293 Cell Line | EDJ-KQ4460 | Human | 1776 | Details Get a Quote |
| DNASE1L2 Knockout HEK293 Cell Line | EDJ-KQ4461 | Human | 1775 | Details Get a Quote |
| DNASE1L1 Knockout HEK293 Cell Line | EDJ-KQ4462 | Human | 1774 | Details Get a Quote |
| DNASE1 Knockout HEK293 Cell Line | EDJ-KQ4465 | Human | 1773 | Details Get a Quote |
| MAP1S Knockout HEK293 Cell Line | EDJ-KQ14193 | Human | 55201 | Details Get a Quote |
| DFFB Knockout A-549 Cell Line | EDJ-KQ22016 | Human | 1677 | Details Get a Quote |
| DFFB Knockout HCT 116 Cell Line | EDJ-KQ22018 | Human | 1677 | Details Get a Quote |
| DFFB Knockout HeLa Cell Line | EDJ-KQ22019 | Human | 1677 | Details Get a Quote |
| DNASE1L2 Knockout HeLa Cell Line | EDJ-KQ27017 | Human | 1775 | Details Get a Quote |
| DNASE1L1 Knockout A-549 Cell Line | EDJ-KQ27018 | Human | 1774 | Details Get a Quote |
| DNASE1L1 Knockout HCT 116 Cell Line | EDJ-KQ27019 | Human | 1774 | Details Get a Quote |
| DNASE1 Knockout A-549 Cell Line | EDJ-KQ27024 | Human | 1773 | Details Get a Quote |
| DNASE1 Knockout HCT 116 Cell Line | EDJ-KQ27025 | Human | 1773 | Details Get a Quote |
| DNASE1 Knockout HeLa Cell Line | EDJ-KQ27026 | Human | 1773 | Details Get a Quote |
Displaying Records 1 To 15 Of 32 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About DNA nuclease activity
What is DNA nuclease activity?
DNA nuclease activity (GO:0004536) is the catalysis of the cleavage of ester linkages within deoxyribonucleic acid, as defined by the Gene Ontology.
What genes are involved in DNA nuclease activity?
Key genes include Cas9, Cas12a2, Exo1, short Argonautes, restriction enzymes, and DNase I.
How is DNA nuclease activity regulated?
It is regulated by substrate recognition, conformational changes, and complex formation with effector proteins.
What diseases are associated with DNA nuclease activity?
Dysregulation is linked to cancer, autoimmune diseases, neurodegeneration, and bacterial infections.
What methods are used to study DNA nuclease activity?
X-ray scattering interferometry, nanoparticle assays, in vitro cleavage assays, and CRISPR screens.
Can CRISPR be used to study DNA nuclease activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used.
What is trans-nuclease activity of Cas9?
It is the ability of Cas9 to cleave non-target DNA upon activation by DNA or RNA target binding.
How does Cas12a2 destroy DNA?
Cas12a2 is activated by RNA and triggers destruction of dsDNA, leading to abortive infection.
What are short Argonautes?
They are DNA-targeting proteins that complex with effectors to mediate collateral nuclease activity and bacterial immunity.
Why is DNA nuclease activity important for research?
It is essential for genome editing, DNA repair studies, and developing antimicrobials and diagnostics.
Conclusion
DNA nuclease activity (GO:0004536) is a cornerstone molecular function with broad implications in genome maintenance, immunity, and disease. The diversity of enzymes, from restriction enzymes to CRISPR effectors, underscores its evolutionary importance and biotechnological potential. Continued research using advanced CRISPR models and biophysical assays will unravel new mechanisms and therapeutic opportunities.
References
- 1. Rosenberg DJ et al.. 2022. Monitoring Nuclease Activity by X-Ray Scattering Interferometry Using Gold Nanoparticle-Conjugated DNA.. Methods Mol Biol 2444:183-205 PMID: 35290639
- 2. Chen J et al.. 2025. Trans-nuclease activity of Cas9 activated by DNA or RNA target binding.. Nat Biotechnol 43(4):558-568 PMID: 38811761
- 3. Li Y et al.. 2019. DNA duplex recognition activates Exo1 nuclease activity.. J Biol Chem 294(30):11559-11567 PMID: 31182486
- 4. Dmytrenko O et al.. 2023. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA.. Nature 613(7944):588-594 PMID: 36599979
- 5. DI Felice F et al.. 2019. Restriction enzymes and their use in molecular biology: An overview.. J Biosci 44(2) PMID: 31180051
- 6. Scholz P et al.. 2026. RNA-triggered cell killing with CRISPR-Cas12a2.. Nature 655(8121):230-239 PMID: 42092133
- 7. Prostova M et al.. 2024. DNA-targeting short Argonautes complex with effector proteins for collateral nuclease activity and bacterial population immunity.. Nat Microbiol 9(5):1368-1381 PMID: 38622379
- 8. Hsiao JC et al.. 2021. Tuning DNA-nanoparticle conjugate properties allows modulation of nuclease activity.. Nanoscale 13(9):4956-4970 PMID: 33629698
